| DHAD | mitoxantrone hydrochloride |
|---|---|
| HCL | hairy-cell leukemia; human cultured lymphoblasts |
| HCl | hydrogen chloride |
| MIT | Mitoxantrone |
|---|---|
| MITO | Mitoxantrone |
| MITOX | Mitoxantrone |
| MTX | Mitoxantrone |
| MX | Mitoxantrone |
| mitoxantrone | <chemical> An anthracenedione antineoplastic agent. It is particularly effective against advanced breast cancer, acute leukaemia, and malignant lymphoma. It has mild side effects, especially with respect to nausea, vomiting, hair loss, and cardiotoxicity. Pharmacological action: analgesics, antineoplastic agent. Chemical name: 9,10-Anthracenedione, 1,4-dihydroxy-5,8-bis((2-((2-hydroxyethyl)amino)ethyl)amino)- (12 Dec 1998) |
|---|---|
| mitoxantrone hydrochloride | 1,4-Dihydro-5,8-bis[[2-[2-hydroxyethyl)-amino]ethyl]anthraquinone dihydrochloride;a synthetic anti-neoplastic used intravenously in the initial therapy for acute nonlymphocytic leukaemia in adults. (05 Mar 2000) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|---|---|---|---|
|
»êÆ®·ÐÁÖ - »õâ
|
Çѱ¹À¯³ªÀÌÆ¼µåÁ¦¾à |
A12941851 | Mitoxantrone HCl | Àü¹®ÀǾàǰ | ±Þ¿© | ºÐ¾÷¿¹¿ÜÀǾàǰ |
|
³ë¹ÝÆ®·ÐÁÖ20mg - »õâ
|
Wyeth |
E02800051 | Mitoxantrone HCl | Àü¹®ÀǾàǰ | ±Þ¿© | ºÐ¾÷¿¹¿ÜÀǾàǰ |
|
¹ÙÀÌÆ®·ÐÁÖ»ç - »õâ
|
¾ÆÁÖ¾àǰ°ø¾÷ |
A05605791 | Mitoxantrone HCl | Àü¹®ÀǾàǰ | »èÁ¦ |
|
³ë¹ÝÆ®·ÐÁÖ10mg - »õâ
|
Wyeth |
E30540021 | Mitoxantrone HCl | Àü¹®ÀǾàǰ | »èÁ¦ |
|
¹ÌÆ®·ÐÁÖ10mg - »õâ
|
ÀÌ¿¬Á¦¾à |
A01451241 | Mitoxantrone HCl | Àü¹®ÀǾàǰ | ±Þ¿© |
|
¹ÌÆ®·ÐÁÖ - »õâ
|
ÀÌ¿¬Á¦¾à |
A01401671 | Mitoxantrone HCl | Àü¹®ÀǾàǰ | ±Þ¿© | ºÐ¾÷¿¹¿ÜÀǾàǰ |
|
Á¨ÆÄµå·ÐÁÖ - »õâ
|
Á¦ÀÌÅØ¹ÙÀÌ¿ÀÁ¨ |
W11960311 | Mitoxantrone HCl | Àü¹®ÀǾàǰ | ±Þ¿© |
|
µ¿±¹¿°»ê¹ÌÅå»êÆ®·ÐÁÖ»ç - »õâ
|
µ¿±¹Á¦¾à |
A00701282 | Mitoxantrone HCl | Àü¹®ÀǾàǰ | »èÁ¦ | ºÐ¾÷¿¹¿ÜÀǾàǰ |
|
Á¾±Ù´ç¹ÌÅä»êÆ®·ÐÁÖ - »õâ
|
Á¾±Ù´ç |
A01250281 | Mitoxantrone HCl | Àü¹®ÀǾàǰ | »èÁ¦ | ºÐ¾÷¿¹¿ÜÀǾàǰ |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|